Acute Coronary Syndrome Market Research
Acute Coronary Syndrome covers the spectrum of clinical conditions ranging from unstable angina to non-ST elevation myocardial infarction and ST elevation myocardial infarction. These life-threatening disorders are a major cause of emergency medical care, hospitalization and mortality.
The Acute Coronary Syndrome (ACS) market research report is a vital source of information and analysis on the global ACS therapeutics market. The face of ACS continues to evolve. The ageing population and pressure of growing risk factors have made a significant impact on the management strategies in ACS. The world market for Acute Coronary Syndrome (ACS) is estimated to reach US$19 billion by the year 2015. This is primarily driven by growing instances of prevalence and incidences in the developed markets of the US and Europe, as well as growing demand for ACS drugs in the rising markets of Brazil, China, India, Mexico and Russia.
The report provides an exhaustive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. It further analyzes market data and analytics in terms of value sales for the global market.
